DVA
71
5
R
61
4
NWSA
71
2
PYPL
33
8
HPE
19
3
GRMN
48
2
MA
60
3
HES
67
4
DLTR
42
-2
DNB
60
2
NWS
66
4
LLY
59
-3
XRAY
17
4
AME
54
6
SNA
46
3
CLX
68
2
DVN
29
2
TGT
42
2
ILMN
28
-2
ORLY
62
9
DVA
71
5
R
61
4
NWSA
71
2
PYPL
33
8
HPE
19
3
GRMN
48
2
MA
60
3
HES
67
4
DLTR
42
-2
DNB
60
2
NWS
66
4
LLY
59
-3
XRAY
17
4
AME
54
6
SNA
46
3
CLX
68
2
DVN
29
2
TGT
42
2
ILMN
28
-2
ORLY
62
9
Financhill
Back

Beta Bionics 10K Form

Sell
29

BBNX
Beta Bionics

Last Price:
$14.74
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BBNX News And Ratings

See the #1 stock for the next 7 days that we like better than BBNX

BBNX Financial Statistics

Sales & Book Value

Annual Sales: $12M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0

Profitability

Net Income (TTM): $0
Gross Margin: $6.3M
Return on Equity: 0%
Return on Assets: 0%

Beta Bionics Earnings Forecast

Key Beta Bionics Financial Ratios

  • The Gross Profit Margin over the past 2 years for BBNX is 52.59%.
  • The Selling, General & Administrative Expenses for BBNX have been equal to 201.88% of Gross Profit Margin.
  • The Research & Development expenses have been 149.59% of Revenue.
  • The Net Earning history of BBNX is -367.64% of Total Revenues.
  • Per Share Earnings over the last 2 years have been positive in 1 years.

Beta Bionics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Current Symbol: BBNX
Website: betabionics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BBNX Technical Analysis vs Fundamental Analysis

Sell
29
Beta Bionics (BBNX) is a Sell

Is Beta Bionics a Buy or a Sell?

  • Beta Bionics stock is rated a Sell
    The current Beta Bionics [BBNX] share price is $14.68. The Score for BBNX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.